Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,250 | 1 | 75.9% |
| Honoraria | $300.00 | 1 | 18.2% |
| Food and Beverage | $96.05 | 6 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Laboratories Inc | $1,250 | 1 | $0 (2017) |
| MacuLogix, Inc. | $300.00 | 1 | $0 (2019) |
| Shire North American Group Inc | $22.57 | 2 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $22.03 | 1 | $0 (2021) |
| AGEPHA Pharma FZ LLC | $21.39 | 1 | $0 (2024) |
| Kyowa Kirin, Inc. | $16.90 | 1 | $0 (2022) |
| GlaxoSmithKline, LLC. | $13.16 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34.55 | 2 | AGEPHA Pharma FZ LLC ($21.39) |
| 2022 | $16.90 | 1 | Kyowa Kirin, Inc. ($16.90) |
| 2021 | $22.03 | 1 | Neurocrine Biosciences, Inc. ($22.03) |
| 2019 | $300.00 | 1 | MacuLogix, Inc. ($300.00) |
| 2018 | $22.57 | 2 | Shire North American Group Inc ($22.57) |
| 2017 | $1,250 | 1 | Alcon Laboratories Inc ($1,250) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Cardiovascular Diseases | ||||||
| 07/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 06/01/2022 | Kyowa Kirin, Inc. | NOURIANZ (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Adenosine A2A Receptors | ||||||
| 12/17/2021 | Neurocrine Biosciences, Inc. | ONGENTYS (Drug), INGREZZA | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: NEUROLOGY | ||||||
| 09/30/2019 | MacuLogix, Inc. | — | Honoraria | Cash or cash equivalent | $300.00 | General |
| Category: Diagnostic Instrument | ||||||
| 07/23/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2018 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2017 | Alcon Laboratories Inc | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 262 | 376 | $380,313 | $100,210 |
| 2022 | 6 | 249 | 403 | $359,288 | $101,916 |
| 2021 | 3 | 143 | 332 | $369,550 | $91,789 |
| 2020 | 5 | 197 | 371 | $402,545 | $96,170 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 34 | 78 | $117,000 | $35,583 | 30.4% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 51 | 107 | $214,000 | $31,389 | 14.7% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 46 | 46 | $13,419 | $10,502 | 78.3% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 46 | 46 | $13,065 | $10,243 | 78.4% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 45 | 45 | $14,729 | $6,976 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 42 | $6,300 | $4,704 | 74.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 12 | 12 | $1,800 | $812.52 | 45.1% |
| 67210 | Destruction of growth of retina using a laser | Office | 2022 | 36 | 71 | $106,500 | $34,167 | 32.1% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2022 | 44 | 100 | $200,000 | $29,882 | 14.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 113 | $16,950 | $13,380 | 78.9% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2022 | 40 | 40 | $11,668 | $9,209 | 78.9% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 39 | 39 | $11,077 | $8,741 | 78.9% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2022 | 40 | 40 | $13,092 | $6,537 | 49.9% |
| 67210 | Laser destruction of retinal growth, 1 or more sessions | Office | 2021 | 40 | 82 | $123,000 | $40,153 | 32.6% |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | Office | 2021 | 50 | 113 | $226,000 | $35,437 | 15.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 137 | $20,550 | $16,200 | 78.8% |
| 67210 | Laser destruction of retinal growth, 1 or more sessions | Office | 2020 | 51 | 93 | $144,000 | $44,831 | 31.1% |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | Office | 2020 | 58 | 115 | $233,000 | $36,526 | 15.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 62 | 129 | $19,350 | $13,103 | 67.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 12 | 12 | $1,920 | $1,400 | 72.9% |
| 92202 | Extended examination of eye with drawing of optic nerve and surrounding area (macula) | Office | 2020 | 14 | 22 | $4,275 | $309.45 | 7.2% |
About Dr. David Berman, MD
Dr. David Berman, MD is a Ophthalmology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942371182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Berman, MD has received a total of $1,646 in payments from pharmaceutical and medical device companies, with $34.55 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($1,250).
As a Medicare-enrolled provider, Berman has provided services to 851 Medicare beneficiaries, totaling 1,482 services with total Medicare billing of $390,085. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Brooklyn, NY
- Active Since 11/10/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942371182
Products in Payments
- MYDAYIS (Drug) $22.57
- ONGENTYS (Drug) $22.03
- LODOCO (Drug) $21.39
- NOURIANZ (Drug) $16.90
- AREXVY (Drug) $13.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Brooklyn
David Rubaltelli, M.d, M.D
Ophthalmology — Payments: $8.9M
Dr. Irene Gladstein, M.d, M.D
Ophthalmology — Payments: $106,815
Mr. Raphael Rosenbaum, M.d, M.D
Ophthalmology — Payments: $40,149
Dr. Leonard Bley, M.d, M.D
Ophthalmology — Payments: $23,405
Dr. Bradley Phillips, M.d, M.D
Ophthalmology — Payments: $16,804
Joseph Zelefsky, Md, MD
Ophthalmology — Payments: $12,170